Prognostic value of proliferating cell nuclear antigen expression in chronic lymphoid leukemia

Auro del Giglio(Faculdade de Medicina do ABC), A. B. Deisseroth, Hideyuki Saya(Fujita Health University Hospital), Adel K. El‐Naggar(Barking, Havering And Redbridge University Hospitals NHS Trust), John T. Manning(The University of Texas Medical Branch at Galveston), Susan O’Brien(University of California, Irvine), R. Ford(Fermi National Accelerator Laboratory), Michael J. Keating(The University of Texas MD Anderson Cancer Center), D. Johnston, Rainer Khetan(The University of Texas MD Anderson Cancer Center)
Blood
May 15, 1992
10.1182/blood.v79.10.2717.bloodjournal79102717
Cited by 25

Related Papers

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
|Blood|2008|3.2k
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k